Global Oncology Market Overview:
Global Oncology Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Oncology Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Oncology involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Oncology Market:
The Oncology Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Oncology Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Oncology Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Oncology market has been segmented into:
Cancer Diagnostics
Cancer Treatment
By Application, Oncology market has been segmented into:
Lungs Cancer
Colorectal Cancer
Breast Cancer
Liver Cancer
Bladder Cancer
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Oncology market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Oncology market.
Top Key Players Covered in Oncology market are:
Roche Holding AG
Novartis AG
Johnson & Johnson
Pfizer Inc.
Merck & Co.
Inc.
Bristol-Myers Squibb Company
AstraZeneca plc
Amgen Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Oncology Market by Type
4.1 Oncology Market Snapshot and Growth Engine
4.2 Oncology Market Overview
4.3 Cancer Diagnostics
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Cancer Diagnostics: Geographic Segmentation Analysis
4.4 Cancer Treatment
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Cancer Treatment: Geographic Segmentation Analysis
Chapter 5: Oncology Market by Application
5.1 Oncology Market Snapshot and Growth Engine
5.2 Oncology Market Overview
5.3 Lungs Cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Lungs Cancer: Geographic Segmentation Analysis
5.4 Colorectal Cancer
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Colorectal Cancer: Geographic Segmentation Analysis
5.5 Breast Cancer
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Breast Cancer: Geographic Segmentation Analysis
5.6 Liver Cancer
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Liver Cancer: Geographic Segmentation Analysis
5.7 Bladder Cancer
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Bladder Cancer: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Oncology Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ROCHE HOLDING AG
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 NOVARTIS AG
6.4 JOHNSON & JOHNSON
6.5 PFIZER INC.
6.6 MERCK & CO.
6.7 INC.
6.8 BRISTOL-MYERS SQUIBB COMPANY
6.9 ASTRAZENECA PLC
6.10 AMGEN INC.
Chapter 7: Global Oncology Market By Region
7.1 Overview
7.2. North America Oncology Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Cancer Diagnostics
7.2.4.2 Cancer Treatment
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Lungs Cancer
7.2.5.2 Colorectal Cancer
7.2.5.3 Breast Cancer
7.2.5.4 Liver Cancer
7.2.5.5 Bladder Cancer
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Oncology Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Cancer Diagnostics
7.3.4.2 Cancer Treatment
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Lungs Cancer
7.3.5.2 Colorectal Cancer
7.3.5.3 Breast Cancer
7.3.5.4 Liver Cancer
7.3.5.5 Bladder Cancer
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Oncology Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Cancer Diagnostics
7.4.4.2 Cancer Treatment
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Lungs Cancer
7.4.5.2 Colorectal Cancer
7.4.5.3 Breast Cancer
7.4.5.4 Liver Cancer
7.4.5.5 Bladder Cancer
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Oncology Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Cancer Diagnostics
7.5.4.2 Cancer Treatment
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Lungs Cancer
7.5.5.2 Colorectal Cancer
7.5.5.3 Breast Cancer
7.5.5.4 Liver Cancer
7.5.5.5 Bladder Cancer
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Oncology Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Cancer Diagnostics
7.6.4.2 Cancer Treatment
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Lungs Cancer
7.6.5.2 Colorectal Cancer
7.6.5.3 Breast Cancer
7.6.5.4 Liver Cancer
7.6.5.5 Bladder Cancer
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Oncology Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Cancer Diagnostics
7.7.4.2 Cancer Treatment
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Lungs Cancer
7.7.5.2 Colorectal Cancer
7.7.5.3 Breast Cancer
7.7.5.4 Liver Cancer
7.7.5.5 Bladder Cancer
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Oncology Scope:
|
Report Data
|
Oncology Market
|
|
Oncology Market Size in 2025
|
USD XX million
|
|
Oncology CAGR 2025 - 2032
|
XX%
|
|
Oncology Base Year
|
2024
|
|
Oncology Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Roche Holding AG, Novartis AG, Johnson & Johnson, Pfizer Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Amgen Inc..
|
|
Key Segments
|
By Type
Cancer Diagnostics
Cancer Treatment
By Applications
Lungs Cancer
Colorectal Cancer
Breast Cancer
Liver Cancer
Bladder Cancer
|
